Patients with persistent fish allergy and parvalbumin sensitization had a low threshold for reactions, which were severe, ...

The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has recommended the approval ...

The Hemophilia B treatment landscape is entering a new era, marked by disruptive innovation, curative potential, and renewed global attention. Once viewed as a lifelong burden requiring constant ...

In recent years, overweight and obesity have become a serious global health problem, posing significant risk factors for ...

Dr. Sean Tucker, Founder and CSO of Vaxart, Urges Stockholders to Vote FOR Reverse Stock Split Proposal by 11:59 p.m. Eastern Time on June 1, 2025 Company Corrects Record on Common Misconceptions ...

Researchers at Moscow’s Sechenov University, in collaboration with the Medical University of Vienna, have developed a ...

As we enter the colder months in Australia, COVID-19 is making headlines again, this time due to the emergence of a new ...

Consolidated sales of 1 M€ at end March 2025 Cash position of 4.1 M€ at March 31, 2025 before collection of Research Tax Credit of 1.08 M€ Anticipated key milestone: feedback from the ...

As we enter the colder months in Australia, COVID is making headlines again, this time due to the emergence of a new variant: ...

It is easy to check these hormone levels as long as a person sees their provider and is honest about the issue, which some ...

The use of the recombinant influenza vaccine can prevent a substantial number of influenza-related hospitalizations among ...

NEW JERSEY, NJ, UNITED STATES, May 26, 2025 /EINPresswire.com/ -- The global biosimilars market is experiencing robust growth as healthcare systems strive to improve patient access to life-saving ...